J. Goldman & Co’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-209,000	Closed	-$1.28M	–	265
2017 Q4	$1.28M	Buy	+209,000	New	+$1.28M	0.07%	130